Guanhao Biotech Co Ltd (300238) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.037x

Based on the latest financial reports, Guanhao Biotech Co Ltd (300238) has a cash flow conversion efficiency ratio of 0.037x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥18.84 Million ≈ $2.76 Million USD) by net assets (CN¥506.03 Million ≈ $74.05 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Guanhao Biotech Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Guanhao Biotech Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Guanhao Biotech Co Ltd total liabilities for a breakdown of total debt and financial obligations.

Guanhao Biotech Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guanhao Biotech Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
American Coastal Insurance Corp
NASDAQ:ACIC
-0.150x
COINSHARES I. LS-000247
F:3TW
N/A
Palm Landscape Architecture Co Ltd
SHE:002431
0.097x
Delpha Construction Co Ltd
TW:2530
0.071x
Shenzhen Ruihe Construction Decoration Co Ltd
SHE:002620
0.206x
Compania General de Electricidad SA
SN:CGE
-0.004x
Shinsung E&G Co. Ltd
KO:011930
0.023x
Ningbo Gaofa Automotive Ctrl
SHG:603788
0.071x

Annual Cash Flow Conversion Efficiency for Guanhao Biotech Co Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of Guanhao Biotech Co Ltd from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see 300238 market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥506.03 Million
≈ $74.05 Million
CN¥71.47 Million
≈ $10.46 Million
0.141x +33.28%
2024-12-31 CN¥467.59 Million
≈ $68.42 Million
CN¥49.55 Million
≈ $7.25 Million
0.106x -10.70%
2023-12-31 CN¥456.26 Million
≈ $66.77 Million
CN¥54.15 Million
≈ $7.92 Million
0.119x -27.96%
2022-12-31 CN¥430.88 Million
≈ $63.05 Million
CN¥70.98 Million
≈ $10.39 Million
0.165x +0.70%
2021-12-31 CN¥748.16 Million
≈ $109.48 Million
CN¥122.39 Million
≈ $17.91 Million
0.164x +12.91%
2020-12-31 CN¥716.66 Million
≈ $104.87 Million
CN¥103.84 Million
≈ $15.19 Million
0.145x +10.24%
2019-12-31 CN¥704.14 Million
≈ $103.04 Million
CN¥92.55 Million
≈ $13.54 Million
0.131x +370.53%
2018-12-31 CN¥1.16 Billion
≈ $169.08 Million
CN¥32.28 Million
≈ $4.72 Million
0.028x +76.29%
2017-12-31 CN¥1.21 Billion
≈ $177.49 Million
CN¥19.22 Million
≈ $2.81 Million
0.016x -24.74%
2016-12-31 CN¥1.46 Billion
≈ $213.26 Million
CN¥30.68 Million
≈ $4.49 Million
0.021x -80.75%
2015-12-31 CN¥620.62 Million
≈ $90.82 Million
CN¥67.87 Million
≈ $9.93 Million
0.109x -11.18%
2014-12-31 CN¥531.61 Million
≈ $77.79 Million
CN¥65.45 Million
≈ $9.58 Million
0.123x +47.83%
2013-12-31 CN¥498.16 Million
≈ $72.90 Million
CN¥41.49 Million
≈ $6.07 Million
0.083x -23.01%
2012-12-31 CN¥454.11 Million
≈ $66.45 Million
CN¥49.12 Million
≈ $7.19 Million
0.108x +32.06%
2011-12-31 CN¥432.79 Million
≈ $63.33 Million
CN¥35.45 Million
≈ $5.19 Million
0.082x -64.81%
2010-12-31 CN¥144.99 Million
≈ $21.22 Million
CN¥33.76 Million
≈ $4.94 Million
0.233x +222.72%
2009-12-31 CN¥76.95 Million
≈ $11.26 Million
CN¥5.55 Million
≈ $812.33K
0.072x -44.41%
2008-12-31 CN¥37.01 Million
≈ $5.42 Million
CN¥4.80 Million
≈ $702.80K
0.130x +55.21%
2007-12-31 CN¥20.67 Million
≈ $3.02 Million
CN¥1.73 Million
≈ $252.86K
0.084x --

About Guanhao Biotech Co Ltd

SHE:300238 China Biotechnology
Market Cap
$551.36 Million
CN¥3.77 Billion CNY
Market Cap Rank
#12026 Global
#3704 in China
Share Price
CN¥14.21
Change (1 day)
-1.52%
52-Week Range
CN¥13.08 - CN¥19.00
All Time High
CN¥56.32
About

Guanhao Biotech Co.,Ltd. develops, manufactures, and sells regenerative medicines and life sciences products primarily in China. It offers NormalGEN, a dura repair patch; GrandNeuro, a dura repair patch; ThormalGEN, a surgical patch; DermalGEN, a wound dressing product; IREAL breast patch; and Youvision corneal graft, as well as license in intraocular lenses. The company also provides Biological … Read more